Mitochondrial abnormalities in patients with LHON-like optic neuropathies

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 10, 2006, Pages 4211-4220

  Abu Amero, Khaled K ^a,d   Bosley, Thomas M ^a,b,c  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

^c Department of Anesthesiology   (United States)

^d Department of Genetics   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BIOCHEMICAL COMPOSITION; BLOOD EXAMINATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE COURSE; DNA CONTENT; DNA SEQUENCE; ELECTRORETINOGRAM; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC PARAMETERS; HAPLOIDY; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MALE; MITOCHONDRIAL ABNORMALITY; MITOCHONDRIAL DNA DISORDER; MITOCHONDRIAL GENE; MITOCHONDRIAL HAPLOGROUP; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOLECULAR BIOLOGY; NEUROIMAGING; NEUROOPHTHALMOLOGY; NUCLEOTIDE SEQUENCE; ONSET AGE; OPA1 GENE; OPA3 GENE; OPTIC NERVE DISEASE; PATHOGENICITY; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; VISUAL ACUITY; VISUAL IMPAIRMENT; CHILD; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRORETINOGRAPHY; GENETICS; HAPLOTYPE; METABOLISM; MUTATION; PROSPECTIVE STUDY; VISUAL FIELD;

GUANOSINE TRIPHOSPHATASE; MITOCHONDRIAL DNA; OPA1 PROTEIN, HUMAN; OPA3 PROTEIN, HUMAN; PROTEIN;

ADOLESCENT; ADULT; CHILD; DNA, MITOCHONDRIAL; ELECTRORETINOGRAPHY; FEMALE; GTP PHOSPHOHYDROLASES; HAPLOTYPES; HUMANS; MALE; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MUTATION; OPTIC ATROPHY, HEREDITARY, LEBER; PROSPECTIVE STUDIES; PROTEINS; SEQUENCE ANALYSIS, DNA; VISUAL ACUITY; VISUAL FIELDS;

EID: 33750593212     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0295     Document Type: Article

References (44)

1. Newman NJ. Hereditary optic neuropathies: from the mitochondria to the optic nerve. Am J Opthalmol. 2005;140:517-523.
2. Wallace D, Singh G, Lott M, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988;242:1427-1430.
3. Mackey DA, Oostra RJ, Rosenberg T, et al. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet. 1996;59:481-485.
4. Fauser S, Luberichs J, Besch D, Leo-Kottler B. Sequence analysis of the complete mitochondrial genome in patients with Leber's hereditary optic neuropathy lacking the three most common pathogenic DNA mutations. Biochem Biophys Res Commun. 2002;295:342-347.
5. Brandon MC, Lott M, Nguyen KC, et al. MITOMAP: A human mitochondrial genome database-2004 update. Available at: http://www.mitomap.org. Nucleic Acids Res. 2005;33:D611-D613.
6. Dogulu CF, Kansu T, Seyrantepe V, et al. Mitochondrial DNA analysis in the Turkish Leber's hereditary optic neuropathy population. Eye 2001;15:183-188.
7. Abu-Amero KK, Bosley TM. Detection of mitochondrial respiratory dysfunction in circulating lymphocytes using resazurin. Arch Pathol Lab Med. 2005;129:1295-1298.
8. Rieder MJ, Taylor SL, Tobe VO, Nickerson DA. Automating the identification of DNA variations using quality-based fluorescence re-sequencing: analysis of the human mitochondrial genome. Nucleic Acids Res. 1998;26:967-973.
9. Herrnstadt C, Elson JL, Fahy E, et al. Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet 2002;70:1152-1171.
10. Kivisild T, Reidla M, Metspalu E, et al. Ethiopian mitochondrial DNA heritage: tracking gene flow across and around the gate of tears. Am J Hum Genet. 2004;75:752-770.
11. Chinnery PF, Howell N, Andrews RM, Turnbull DM. Mitochondrial DNA analysis: polymorphisms and pathogenicity. J Med Genet. 1999;36:505-510.
12. Sunyaev S, Ramensky V, Koch I, et al. Prediction of deleterious human alleles. Hum Mol Genet. 2001;10:591-597.
13. Ng PC, Henikoff S. Accounting for human polymorphisms predicted to affect protein function. Genome Res. 2002;12:436-446.
14. Fahy E, Nazarbaghi R, Zomorrodi M, et al. Multiplex fluorescence-based primer extension method for quantitative mutation analysis of mitochondrial DNA and its diagnostic application for Alzheimer's disease. Nucleic Acids Res. 1997;25:3102-3109.
15. Kao SH, Chao HT, Liu HW, et al. Sperm mitochondrial DNA depletion in men with asthenospermia. Fertil Steril. 2004;82:66-73.
16. Thiselton DL, Alexander C, Taanman JW, et al. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy. Invest Ophthalmol Vis Sci. 2002;43:1715-1724.
17. Anikster Y, Kleta R, Shaag A, et al. Type III 3-methylglutaconic aciduria (Optic Atrophy Plus Syndrome, or Costeff Optic Atrophy Syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am J Hum Genet. 2001;69:1218-24.
18. Smith JL, Hoyt WF, Susac JO. Ocular fundus in acute Leber optic neuropathy. Arch Ophthalmol. 1973;90:349-354.
19. Acaroglu G, Kansu T, Dogulu CF. Visual recovery patterns in children with Leber's hereditary optic neuropathy. Int Ophthalmol. 2001;24:349-355.
20. Stone EM, Newman NJ, Miller NR, et al. Visual recovery in patients with Leber's hereditary optic neuropathy and the 11778 mutation. J Clin Neuroophthalmol. 1992;12:10-14.
21. Smith KH, Johns DR, Heher KL, Miller NR. Heteroplasmy in Leber's hereditary optic neuropathy. Arch Ophthalmol. 1993;111:1486-1490.
22. Black GC, Morten K, Laborde A, Poulton J. Leber's hereditary optic neuropathy: heteroplasmy is likely to be significant in the expression of LHON in families with the 3460 ND1 mutation. Br J Ophthalmol. 1996;80:915-917.
23. Brown MD, Starikovskaya E, Derbeneva O, et al. The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup J. Hum Genet. 2002;110:130-138.
24. Petros JA, Baumann AK, Ruiz-Pesini E, et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA. 2005;102:719-724.
25. Taylor RW, Barron MJ, Borthwick GM, et al. Mitochondrial DNA mutations in human colonic crypt stem cells. J Clin Invest. 2003;112:1351-1360.
26. Yen MY, Chen CS, Wang AG, Wei YH. Increase of mitochondrial DNA in blood cells of patients with Leber's hereditary optic neuropathy with 11778 mutation. Br J Ophthalmol. 2002;86:1027-1030.
27. Cock HR, Cooper JM, Schapira AH. Functional consequences of the 3460-bp mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. J Neurol Sci. 1999;165:10-17.
28. Brown MD, Trounce IA, Jun AS, et al. Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber's hereditary optic neuropathy mitochondrial DNA mutation. J Biol Chem. 2000;275:39831-39836.
29. Carelli V, Ghelli A, Bucchi L, et al. Biochemical features of mtDNA 14484 (ND6/M64V) point mutation associated with Leber's hereditary optic neuropathy. Ann Neurol. 1999;45:320-328.
30. Howell N. LHON and other optic nerve atrophies: the mitochondrial connection. Dev Ophthalmol. 2003;37:94-108.
31. Barron MJ, Griffiths P, Turnbull DM, et al. The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br J Ophthalmol. 2004;88:286-290.
32. Polster BM, Fiskum G. Mitochondrial mechanisms of neural cell apoptosis. J Neurochem. 2004;90:1281-1289.
33. Zanna C, Ghelli A, Porcelli AM, et al. Apoptotic cell death of cybrid cells bearing Leber's hereditary optic neuropathy mutations is caspase independent. Ann NY Acad Sci. 2003;1010:213-217.
34. Lightowlers RN, Chinnery PF, Turnbull DM, Howell N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet. 1997;13:450-455.
35. Lee HC, Wei YH. Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol. 2005;37:822-834.
36. Horvath J, Horvath R, Karcagi V, et al. Sequence analysis of Hungarian LHON patients not carrying the common primary mutations. J Inherit Metab Dis. 2002;25:323-324.
37. Zeviani M, Spinazzola A, Carelli V. Nuclear genes in mitochondrial disorders. Curr Opin Genet Dev. 2003;13:262-270.
38. Carelli V, Giordano C, d'Amati G. Pathogenic expression of homoplasmic mtDNA mutations needs a complex nuclear-mitochondrial interaction. Trends Genet. 2003;19:257-262.
39. Sadun A. Acquired mitochondrial impairment as a cause of optic nerve disease. Trans Am Ophthalmol Soc. 1998;96:881-923.
40. Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23:53-89.
41. Nikoskelainen EK, Huoponen K, Juvonen V, et al. Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology. 1996;103:504-514.
42. Lamminen T, Huoponen K, Sistonen P, et al. mtDNA haplotype analysis in Finnish families with leber hereditary optic neuroretinopathy. Eur J Hum Genet. 1997;5:271-279.
43. Man PY, Griffiths PG, Brown DT, et al. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet. 2003;72:333-339.
44. Mackey DA, Buttery RG. Leber hereditary optic neuropathy in Australia. Aust N Z J Ophthalmol. 1992;20:177-184.